Scaling up community-based cervical cancer screening in Cameroon employing a single visit approach

Grohar, Damien; Vassilakos, Pierre; Benkortbi, Khadidja; Tincho, Evelyn; Petignat, Patrick

doi:10.1136/ijgc-2020-001422

Cited by 10 publications

(14 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ministry of Public Health of Cameroon initiated a pilot cervical cancer screening program in 2018 using low-cost HPV detection test in West Cameroon and was in the process of scaling up to other regions. 17 Morocco adopted a strategic cancer control plan in 2010 and implemented breast cancer screening with clinical breast examination across all regions of the country. 18 The program achieved more than 60% annual coverage of the target population within 5 years of initiation.…”

Section: Discussionmentioning

confidence: 99%

Cross‐sectional survey of the impact of the COVID‐19 pandemic on cancer screening programs in selected low‐ and middle‐income countries: Study from the IARC COVID‐19 impact study group

Villain

Carvalho

Lucas

et al. 2021

Intl Journal of Cancer

View full text Add to dashboard Cite

We conducted a study to document the impact of COVID‐19 pandemic on cancer screening continuum in selected low‐ and middle‐income countries (LMICs). LMICs having an operational cancer control plan committed to screen eligible individuals were selected. Managers/supervisors of cancer screening programs were invited to participate in an online survey and subsequent in‐depth interview. Managers/supervisors from 18 programs in 17 countries participated. Lockdown was imposed in all countries except Brazil. Screening was suspended for at least 30 days in 13 countries, while diagnostic‐services for screen‐positives were suspended in 9 countries. All countries except Cameroon, Bangladesh, India, Honduras and China managed to continue with cancer treatment throughout the outbreak. The participants rated service availability compared to pre‐COVID days on a scale of 0 (no activities) to 100 (same as before). A rating of ≤50 was given for screening services by 61.1%, diagnostic services by 44.4% and treatment services by 22.2% participants. At least 70% participants strongly agreed that increased noncompliance of screen‐positive individuals and staff being overloaded or overwhelmed with backlogs would deeply impact screening programs in the next 6 months at least. Although many of the LMICs were deficient in following the “best practices” to minimize service disruptions, at least some of them made significant efforts to improve screening participation, treatment compliance and program organization. A well‐coordinated effort is needed to reinitiate screening services in the LMICs, starting with a situational analysis. Innovative strategies adopted by the programs to keep services on‐track should be mutually shared.

show abstract

Section: Discussionmentioning

confidence: 99%

Cross‐sectional survey of the impact of the COVID‐19 pandemic on cancer screening programs in selected low‐ and middle‐income countries: Study from the IARC COVID‐19 impact study group

Villain

Carvalho

Lucas

et al. 2021

Intl Journal of Cancer

View full text Add to dashboard Cite

show abstract

“…Cameroon, an SSA country, has about half (50.1%) of its population being females and at risk of the disease [19]. Nationally, the disease is the second most common cancer in women and the leading cause of cancer-related deaths [19], with a reported prevalence of 19.6 and 24% among childbearing women in two different districts [20,21]. It ranks second in the annual cancer cases, with over 15,700 new cases annually and a mortality-toincidence ratio above 65% [22].…”

Section: Introductionmentioning

confidence: 99%

Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys

et al. 2021

View full text Add to dashboard Cite

Background Cervical cancer, although preventable, is the fourth most common cancer among women globally, and the second most common and deadliest gynaecological cancer in low-and-middle-income countries. Screening is key to the prevention and early detection of the disease for treatment. A few studies estimated the prevalence of cervical cancer screening and its correlates in Cameroon but relied on data that were limited to certain regions of the country. Therefore, this study sought to examine the prevalence and correlates of cervical cancer screening among Cameroonian women using current data that is nationally representative of reproductive-age women. Methods We used secondary data from the 2018 Cameroon Demographic and Health Survey. Summary statistics were used for the sample description. We employed the Firth logistic regression using the “firthlogit” command in STATA-14 to perform the bivariate analyses between the outcome variable and each of the explanatory variables. Given that all the explanatory variables were statistically significant correlates, they were all adjusted for in a multivariable analysis. All analyses were performed in STATA version 14. Results The proportion of Cameroonian women who have ever screened for cervical cancer continue to remain low at approximately 4%. In the adjusted model, women with the following sociodemographic characteristics have a higher likelihood of undergoing cervical cancer screening: ever undergone HIV screening (AOR = 4.446, 95% CI: 2.475, 7.986), being 24–34 years (AOR = 2.233, 95% CI: 1.606, 3.103) or 35–44 years (AOR = 4.008, 95% CI: 2.840, 5.657) or at least 45 years old (AOR = 5.895, 95% CI: 3.957, 8.784), having attained a post-secondary education (AOR = 1.849, 95% CI: 1.032, 3.315), currently (AOR = 1.551, 95% CI: 1.177, 2.043) or previously married (AOR = 1.572, 95% CI: 1.073, 2.302), dwelling in the richest household (AOR = 4.139, 95% CI: 1.769, 9.682), and residing in an urban area (AOR = 1.403, 95% CI: 1.004,1.960). Except for the North-West region, residing in some five regions, compared to Yaounde, was negatively associated with cervical cancer screening. Conclusion Cervical cancer screening programs and policies should target Cameroonian women who are younger, less educated, and those in poor households and rural areas.

show abstract

“…However, despite the free provision of clinical services, in the first 6 months the program revealed a 50% lower participation rate than expected [7]. Although previous quantitative studies in SSA have identified a lack of knowledge as an important barrier to CC screening, additional factors may also contribute to the lower participation rate [8][9][10]. To understand the complex barriers affecting women's decision processes regarding participation in CC screening, a qualitative study was conducted to explore the perspectives of women and their partners in the Dschang district.…”

Section: Introductionmentioning

confidence: 79%

“…Following rapid HPV testing (Xpert TM HPV), HPV-negative women are reassured and advised to undertake a next screening 5 years later. HPV-positive women undergo visual inspection with acetic acid and visual inspection with iodine (VIA/VILI) and treatment (if indicated) or follow-up [10]. Further details can be found in a recent publication [10].…”

Section: Plain Language Summarymentioning

confidence: 99%

“Cervical cancer screening: awareness is not enough”. Understanding barriers to screening among women in West Cameroon—a qualitative study using focus groups.

et al. 2021

Self Cite

View full text Add to dashboard Cite

Background Cervical cancer is the second leading cause of cancer-related death among women in sub-Saharan countries, constituting a major public health concern. In Cameroon, cervical cancer ranks as the second most common type of cancer among women and the leading cause of cancer-related deaths, mainly due to the lack of prevention. Objectives Our first and main objective was to understand the barriers affecting women’s decision-making process regarding participation in a cervical cancer screening program in the Dschang district (West Cameroon). Second, we aimed to explore the acceptability and perception of a single-visit approach (screen and treat). Methods A qualitative study using focus groups (FGs) was conducted from February to March 2020. Female participants aged between 30 and 49 years and their male partners were invited to participate. Thematic analysis was used, and barriers were classified according to the three-delay model of Thaddeus and Maine. Results In total, six FGs with 43 participants (31 women and 12 men) were conducted. The most important barriers were lack of health literacy, low accessibility of the program (in respect to cost and distance), and disrespectful treatment by healthcare workers. Conclusions Our study identified three needs: (1) enhancing health literacy; (2) improving the delivery of cervical cancer screening in rural areas; and (3) providing training for healthcare providers and community healthcare workers to improve patient-provider-communication. Trial registration Ethical Cantonal Board of Geneva, Switzerland (CCER, N°2017-0110 and CER-amendment n°3) and Cameroonian National Ethics Committee for Human Health Research (N°2018/07/1083/CE/CNERSH/SP). NCT: 03757299

show abstract

Scaling up community-based cervical cancer screening in Cameroon employing a single visit approach

Cited by 10 publications

References 4 publications

Cross‐sectional survey of the impact of the COVID‐19 pandemic on cancer screening programs in selected low‐ and middle‐income countries: Study from the IARC COVID‐19 impact study group

Cross‐sectional survey of the impact of the COVID‐19 pandemic on cancer screening programs in selected low‐ and middle‐income countries: Study from the IARC COVID‐19 impact study group

Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys

“Cervical cancer screening: awareness is not enough”. Understanding barriers to screening among women in West Cameroon—a qualitative study using focus groups.

Contact Info

Product

Resources

About